Skip to content

i-PRF and the TMJ: A Better Way to Manage Internal Derangement?

A COMPARATIVE EVALUATION OF ARTHROCENTESIS WITH AND WITHOUT INJECTABLE PLATELET RICH FIBRIN FOR MANAGEMENT OF INTERNAL DERANGEMENT OF THE TEMPOROMANDIBULAR JOINT - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/109930
Enrollment
32
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M248- Other specific joint derangements,not elsewhere classified

Interventions

Intervention1: Convention Double Puncture Arthrocentesis followed by 2 ml of i-PRF injected into joint space: The antiseptic solution (5% povidone iodine) will be used to prepare the surgical site. A
the third point (Point C) will be located 20 mm in front of the tragus and 10 mm below the CTL. Two 18-gauge needles will be introduced through the designated locations after an auriculotemporal nerve
10 milliliters of peripheral blood will be collected from the antecubital vein of the patient in empty collection tubes, (i.e. without any additives). The blood collection tubes will be centrifuged at

Sponsors

Sardar Patel Postgraduate institute of dental and medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presence of unilateral Anterior disc displacement with and without reduction 2. Age greater than 18 years 3. Patients who fall within the ASA 1 or 2 (American Society of Anaesthesiology) classification 4. Presence of localized temporomandibular joint pain 5. Stages 2 - 4 in the Wilkes classification. 6. Mouth opening less than 35 mm 7. Clicking or Popping sound 8. Refractory to conservative method for at least 6 months 9. Pain on wide mouth opening and protrusive and or lateral excursion movements

Exclusion criteria

Exclusion criteria: 1. Previous history of Trauma or TMJ Surgery 2. Dentofacial deformity 3. Psychiatric illness 4. Chronic headache 5. Undergoing Orthodontic treatment 6. Significant mechanical obstruction that prevents mouth opening 7. Acute capsulitis 8. Benign or malignant temporomandibular joint lesions 9. Neurological disorders 10. Haematological disorders 11. Patients with a previous history of allergy or anaphylactic shock.

Design outcomes

Primary

MeasureTime frame
Primary outcomes to be evaluated are 1. Improvement in the range of motion, including protrusive and lateral excursive movement of jaw 2. Improvement in postoperative pain assessed using 10 cm Visual analog scaleTimepoint: 1. 7th postoperative day 2. 14th postoperative day 3. 21st postoperative day 4. 30th postoperative day 5. 90th postoperative day 6. 180th postoperative day

Secondary

MeasureTime frame
Secondary outcomes to be evaluated are 1. Improvement in maximum interincisal opening 2. Improvement in Clinical dysfunction using Helkimo clinical dysfunction scoring 3. improvement in bite force using gnathodynamometer in both th groupsTimepoint: 1. 7th postoperative day 2. 14th postoperative day 3. 21st postoperative day 4. 30th postoperative day 5. 90th postoperative day 6. 180th postoperative day

Countries

India

Contacts

Public ContactDr Shubhamoy Mondal

Sardar patel post graduate institute of dental and medical sciences

dr.shubhamoy@gmail.com7800899044

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026